1. Home
  2. WCN vs ZTS Comparison

WCN vs ZTS Comparison

Compare WCN & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waste Connections Inc.

WCN

Waste Connections Inc.

N/A

Current Price

$193.82

Market Cap

41.9B

Sector

Utilities

ML Signal

N/A

Logo Zoetis Inc.

ZTS

Zoetis Inc.

N/A

Current Price

$83.62

Market Cap

33.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WCN
ZTS
Founded
1997
1952
Country
Canada
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.9B
33.5B
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
WCN
ZTS
Price
$193.82
$83.62
Analyst Decision
Strong Buy
Hold
Analyst Count
28
16
Target Price
★ $206.56
$89.69
AVG Volume (30 Days)
2.2M
★ 4.1M
Earning Date
10-21-2026
11-05-2026
Dividend Yield
0.79%
★ 2.56%
EPS Growth
★ 74.48
10.05
EPS
3.45
★ 4.51
Revenue
$9,466,915,000.00
★ $9,467,000,000.00
Revenue This Year
$6.63
N/A
Revenue Next Year
$6.03
$0.54
P/E Ratio
$56.12
★ $18.38
Revenue Growth
★ 6.14
2.28
52 Week Low
$146.89
$68.92
52 Week High
$195.39
$132.49

Technical Indicators

Market Signals
Indicator
WCN
ZTS
Relative Strength Index (RSI) 73.24 58.55
Support Level $152.15 $71.78
Resistance Level N/A $89.29
Average True Range (ATR) 4.37 2.63
MACD 0.16 -0.08
Stochastic Oscillator 87.18 54.49

Price Performance

Historical Comparison
WCN
ZTS

About WCN Waste Connections Inc.

Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: